Skip to main content

Table 2 Radiosurgical planning data for extrapolation of excess brain irradiated during SRS treatments for both pre- versus post-surgery. (GTV = gross tumor volume)

From: Pre-operative stereotactic radiosurgery treatment is preferred to post-operative treatment for smaller solitary brain metastases

PT# Pathology   GTV GTV + 3 mm Isodose volume Excess Brain IDL/GTV
PRE POST PRE POST PRE POST PRE POST PRE POST
1 NSCLC   14.85 27.67 35.1 48.79 52.28 72.19 24.51 29.08 3.520539 2.608963
2 Bladder/transitional cell   3.36 3.39 11.45 11.83 15.86 18.38 11.99 14.39 4.720238 5.421829
3 NSCLC   23.89 8.97 41 16.73 57.38 22.98 26.16 13.54 2.401842 2.561873
4 Lung-papillary adenocarcinoma   0.34 2.33 1.84 6.81 2.57 10.41 1.97 7.34 7.558824 4.467811
5 Carcinoid   67.88 6.06 116.62 17.79 165.83 27.53 93.5 20.52 2.442988 4.542904
6 NSCLC   37.32 27.81 63.61 53.71 101.23 90.5 61.77 62.11 2.712487 3.254225
7 melanoma   0.06 5.85 0.79 18.16 1.09 31.05 0.97 18.22 18.16667 5.307692
8 Lung-papillary adenocarcinoma   2.8 9.57 7.4 21.87 10.93 27.53 6.73 13.22 3.903571 2.876698
9 NSCLC   1.8 5.87 5.68 14.34 8.6 21.02 6.78 12.39 4.777778 3.58092
10 Lung adenocarcinoma   0.33 1.55 1.82 7.05 2.8 9.92 2.44 7.07 8.484848 6.4
10 Lung adenocarcinoma   17.39 4.8 32.3 17.04 47.78 24.22 23.49 14.36 2.747556 5.045833
11 Lung squamous cell   11.38 22.18 22.78 45.05 35.57 82.05 17.41 33.59 3.125659 3.699279
12 Lung adenocarcinoma   6.09 9.64 14.11 20.74 22.73 32.16 13.02 15.6 3.732348 3.3361
   min 0.06 1.55 0.79 6.81 1.09 9.92 0.97 7.07   
   max 67.88 27.81 116.62 53.71 165.83 90.5 93.5 62.11   
   average 14.42231 10.43769 27.26923 23.07 40.35769 36.14923 22.36462 20.11